NEW YORK, NY -- March 11, 2024 -- InvestorsHub NewsWire --
Applied UV, Inc. ("Applied UV" or the "Company") (Nasdaq:
AUVI), a leader in smart building technology
solutions, today announced that its SteriLumen subsidiary has
filed a new patent application with the United States Patent and
Trademark Office ("USPTO") entitled "Disinfection System
Comprised of Multiple Wavelengths Each Controlled
Optimally" with claims pertaining to a method
of integrating disinfection systems uniquely designed to
optimize environmental cleanliness across different rates of
occupancy within healthcare settings, especially operating rooms.
Management estimates the annual market size to be in excess of
$150M per year with roughly 4,000 operating rooms renovated
annually in the United States.
The demand for effective disinfection methods in healthcare
environments, particularly operating rooms, has never been more
critical. Traditional chemical-based approaches often fall short in
terms of safety, effectiveness, and ease of use, especially in
occupied spaces. Additionally, the risk of pathogen transmission in
these critical areas necessitates innovative solutions to ensure a
sterile environment not only during surgical procedures but also in
the intervals between them.
The cornerstone of this novel system is the PURONet Control
System, which represents a seamless integration of the best
elements of continuous and terminal disinfection methods. The
PURONet Control System serves as the central nervous system,
seamlessly interfacing with the Puro Protect 222 system for safe,
continuous disinfection during occupancy, and the Helo LED system
for deep, terminal disinfection when spaces are unoccupied.
This dual approach marries the necessity of continuous low-level
disinfection with the thoroughness of terminal cleaning cycles,
ensuring optimal safety and efficiency. The Puro Protect 222 system
operates discreetly in the background, providing non-invasive
disinfection while rooms are in use, thus ensuring operations can
continue without interruption. Once vacated, the Helo LED system
takes over, employing a powerful spectrum of UV light to thoroughly
disinfect the environment, preparing it for the next use.
By integrating these two disinfection states, the PURONet
Control System not only optimizes energy use but also extends the
life cycle of the fixtures while enhancing the safety of patients
and staff through its intelligent, adaptive control. This
integrated approach underscores Applied UV's strategic focus on
delivering innovative, energy-efficient, and effective disinfection
solutions that meet the rigorous demands of modern healthcare
environments.
Today, the Company's SteriLumen subsidiary has provided its
disinfections systems to such renowned hospitals as University of
Chicago Medical Center, Kansas City Mercy Children's
Hospital, University of Texas Health Systems, and Mass
General, Harvard University as well as many others.
PURO Protect 222
Troffer Innovation and Benefits:
-
Safety in Occupied Spaces: The Puro Protect 222
system allows for continuous disinfection without evacuating the
room, making it ideal for high-traffic healthcare environments.
-
Effective Terminal Disinfection: The Helo LED
system provides a robust solution for deep disinfection of
unoccupied spaces, targeting a broad range of pathogens.
-
Optimized Control: The PURONet Control System
intelligently manages the operation of both systems, ensuring that
disinfection processes are optimized for safety, energy efficiency,
and efficacy based on real-time occupancy data.
-
Design Flexibility: The integrated fixtures are
designed for versatile installation, fitting seamlessly into
existing healthcare infrastructure with minimal disruption.
-
Comprehensive Disinfection: By combining
different wavelengths of light controlled through an intelligent
system, this invention provides a layered approach to disinfection,
significantly reducing the risk of pathogen transmission.
"We continue to build a robust intellectual property ("IP")
portfolio that supports our strategic focus of providing our
healthcare customers innovative, energy efficient and
cost-effective air disinfection systems," stated Max Munn, CEO
of Applied UV Inc. "We believe the new PURONet
patent represents a significant advancement in healthcare
disinfection technology. By leveraging the unique properties of
various wavelengths and integrating them into a smart, responsive
system, this invention offers a novel solution to the challenges of
maintaining sterile environments in operating rooms and similar
settings, enhancing patient and staff safety."
About PURO UV Disinfection Lighting
PURO UV Disinfection Lighting promotes health and safety by
bringing proven and powerful UV light disinfection devices to all
indoor spaces where people gather including hospitals, schools and
universities, medical and manufacturing facilities, transportation,
office buildings, and much more, all without the use of chemicals.
From HVAC systems to in room and upper air disinfection, PURO
Lighting products offer a wide variety of UV technologies to
provide continuous disinfection of air in occupied spaces and can
rapidly disinfect any indoor area inactivating viruses, bacteria,
fungi and more including SARS-CoV-2 virus.
About Applied UV
Applied UV Inc. is dedicated to developing and acquiring smart
building technologies for healthcare, hospitality, commercial and
municipal markets. With SteriLumen, MunnWorks, LED Supply Co., and
PURO, the company has a diverse portfolio that addresses various
needs in the market. Applied UV Inc. is committed to innovation and
excellence in providing solutions for a healthier and smarter
world. More details about Applied UV, Inc., and its subsidiaries
can be found at applieduvinc.com.
Forward-Looking Statements
The information contained herein may contain "forward-looking
statements." Forward-looking statements reflect the current view
about future events. When used in this press release, the words
"anticipate," "believe," "estimate," "expect," "future," "intend,"
"plan," or the negative of these terms and similar expressions, as
they relate to us or our management, identify forward-looking
statements. Such statements include, but are not limited to,
statements contained in this press release relating to its business
strategy. Forward-looking statements are based on the Company's
current expectations and assumptions regarding its business, the
economy and other future conditions. Because forwardlooking
statements relate to the future, they are subject to inherent
uncertainties, risks and changes in circumstances that are
difficult to predict. The Company's actual results may differ
materially from those contemplated by the forward-looking
statements. They are neither statements of historical fact nor
guarantees of assurance of future performance. We caution you
therefore against relying on any of these forward-looking
statements. Factors or events that could cause the Company's actual
results to differ may emerge from time to time, and it is not
possible for the Company to predict all of them. These
forward-looking statements and factors that may cause such
differences include, without limitation, the risks disclosed in the
Company's Annual Report on Form 10-K filed with the SECon March 31,
2023, and in the Company's subsequent filings with the SEC. The
Company cannot guarantee future results, levels of activity,
performance, or achievements. Except as required by applicable law,
including the securities laws of the United States, the Company
does not intend to update any of the forward-looking statements.
References and links to websites have been provided as a
convenience, and the information contained on such websites is not
incorporated by reference into this press release.
For Additional Company Information:
Applied UV, Inc.
Max Munn
Applied UV Founder, CEO & Director
Max.munn@applieduvinc.com
Investor Relations Contact:
TraDigital IR
Kevin McGrath
+1-646-418-7002
kevin@tradigitalir.com
